Elderly patients are at greater risk for adverse drug effects than younger people. Because most adverse effects are related to dose, conventional wisdom holds that drug therapy should be initiated at low doses. However, clinicians face several challenges when prescribing low-dose therapy for their older patients. This article presents three clinical scenarios to illustrate some of these challenges.<\/p>\n","protected":false},"excerpt":{"rendered":"
Elderly patients are at greater risk for adverse drug effects than younger people. Because most adverse effects are related to dose, conventional wisdom holds that drug therapy should be initiated at low doses. However, clinicians face several challenges when prescribing low-dose therapy for their older patients. This article presents three clinical scenarios to illustrate some […]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"topic":[17,56],"migration-helper-qa-sample-set":[],"class_list":["post-6380","journal_article","type-journal_article","status-publish","hentry","topic-older-people","topic-pharmacoepidemiology-and-drug-safety"],"acf":{"citation":"Rochon PA, Clark JP, Gurwitz JH. CMAJ<\/em>. 1999; 160(7):1029-31.","source_url":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1230198\/","ices_scientist":[1340],"site":[6735],"research_program":[6746],"news_release":[],"journal_article":[],"atlas":[],"research_report":[],"infographic":[],"video":[],"downloads":null,"links":null,"sitecore_item_id":"9B8DD7B6-7127-4A3F-AEF2-DDD2A4E251E4","sitecore_item_name":"Challenges-of-prescribing-low-dose-drug-therapy-for-older-people","sitecore_field_values":"{\n \"Title\": \"Challenges of prescribing low-dose drug therapy for older people\",\n \"Short title\": \"Challenges of prescribing low-dose drug\",\n \"Citation\": \"